ARCHIVES

House Committee Aims To Cut Markup On Office-Administered Cancer Drugs.

This article is from The Cancer Letter archive.

Vol. 27 No. 42 | November 16, 2001

Download PDF Visit The Full Archive

Related Articles

Group Chairs Urge NCI to Limit Authority of Steering Committees That Determine Which Trials Get Funded

August 5, 2011

GAO Says Multiple Year Funding Not Legal; Weicker Demands Assurance That Administration Will Comply

March 29, 1985

FDA Approves Avastin For Recurrent NSCLC

October 27, 2006

CDC Funds Early Detection Programs In Eight States

August 23, 1991

NCCS Networker Volume 3 Issue 3, Summer 1989

June 13, 1989

Lines Drawn Over HHS Appropriations.

October 5, 2007